p66Shc protein is upregulated by steroid hormones in hormone-sensitive cancer cells and in primary prostate carcinomas

Authors

  • Ming-Shyue Lee,

    1. Department of Biochemistry and Molecular Biology, College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA
    Search for more papers by this author
    • The first two authors contributed equally to this article.

  • Tsukasa Igawa,

    1. Department of Biochemistry and Molecular Biology, College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA
    Current affiliation:
    1. Department of Urology, Nagasaki University School of Medicine, Sakamoto 1-7-1 Nagasaki 852-8501, Japan
    Search for more papers by this author
    • The first two authors contributed equally to this article.

  • Siu-Ju Chen,

    1. Department of Biochemistry and Molecular Biology, College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA
    Search for more papers by this author
  • Dana Van Bemmel,

    1. Department of Biochemistry and Molecular Biology, College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA
    Search for more papers by this author
  • Jamie S. Lin,

    1. Department of Biochemistry and Molecular Biology, College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA
    Search for more papers by this author
  • Fen-Fen Lin,

    1. Department of Biochemistry and Molecular Biology, College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA
    Search for more papers by this author
  • Sonny L. Johansson,

    1. Department of Pathology, College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA
    Search for more papers by this author
  • Judith K. Christman,

    1. Department of Biochemistry and Molecular Biology, College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA
    2. Eppley Institute for Cancer Research, University of Nebraska Medical Center, Omaha, NE, USA
    Search for more papers by this author
  • Ming-Fong Lin

    Corresponding author
    1. Department of Biochemistry and Molecular Biology, College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA
    2. Department of Surgery/Urology, College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA
    3. Eppley Institute for Cancer Research, University of Nebraska Medical Center, Omaha, NE, USA
    • Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, 984525 Nebraska Medical Center, Omaha, NE 68198-4525
    Search for more papers by this author
    • Fax: +402-559-6650


Abstract

Members of Shc family conventionally serve as critical adaptors in tyrosine phosphorylation signal transduction pathways. p66Shc protein, a member of Shc family, is predominantly expressed in epithelial cells, whereas the regulation of its expression remains an enigma. We describe the effect of steroid hormones on the protein level of p66Shc and growth stimulation in hormone-sensitive human prostate, testicular and breast cancer cells. In DHT-treated androgen-sensitive prostate cancer LNCaP C-33 cells, the protein level of p66Shc was elevated by approximately 3-fold, correlating with increased cell growth. This DHT effect on p66Shc protein level and growth regulation was also observed in another androgen-sensitive prostate cancer cell line MDA PCa2b as well as 2 testicular cancer cell lines, Tera-1 and Tera-2 cells. Similarly, the female sex hormone estrogen had a stimulating effect on p66Shc protein level and proliferation in estrogen-sensitive MCF-7 breast cancer cells. The upregulation of p66Shc protein level by DHT was competitively abolished by Casodex, an androgen antagonist used to treat prostate cancer. Moreover, immunohistochemical analyses showed that the p66Shc protein level was significantly higher in primary prostate tumors than in adjacent non-cancerous cells (p < 0.05). The data collectively indicate that p66Shc protein levels correlate with steroid hormone-stimulated cell growth and prostate carcinogenesis. © 2003 Wiley-Liss, Inc.

Ancillary